FindTrial
Sign In

To evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types

evaluation of dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types - None

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/01/005459
Enrollment
24
Registered
2015-01-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Silk Lotion SSK30-IIL-78002 Silk lotion SSK30-IIL-72009 Body spray SSK 062 080/TH Body Spray SSKS 007 021/CC Body spray SSKS 077 021/TH Body spray SSS 062 080 KMQ: Skin lotion is leave

Sponsors

ITC RD CENTRE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Skin is healthy on the studied anatomic unit (free of eczema,wounds, inflammatory scarââ?¬Â¦.) Subjects representing varied skin types (ideally equal representation of all 4 skin types ââ?¬â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period

Exclusion criteria

Exclusion criteria: For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

Design outcomes

Primary

MeasureTime frame
To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types Timepoint: To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types on t0,t1,t2 and t8 day visit—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactDr Mary Francis

MASCOT-SPINCONTROL

mary@mascotspincontrol.in022-43349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026